In a January 22, 2026, hearing before the Health subcommittee of the U.S. House Energy and Commerce Committee, lawmakers laid out how today’s prescription drug market actually operates: The same corporate families controlling the insurer, the PBM, the pharmacy, the clinic, and even the drug manufacturer. What was described on the record wasn’t competition: It was control.
Pharmacists and patients live with the consequences every day: Higher out-of-pocket costs, denied medications, opaque rebates, and fewer real choices at the pharmacy counter. The video below captures a rare, unfiltered moment where these practices are confronted directly. Watch the hearing highlights in full.